The molecular interaction of human anti-apoptotic proteins and in silico ADMET, drug-likeness and toxicity computation of N-cyclohexylmethacrylamide

被引:5
|
作者
Cankaya, Nevin [1 ]
Azarkan, Serap Yalcin [2 ]
Tanis, Emine [3 ]
机构
[1] Usak Univ, Dept Chem, Usak, Turkey
[2] Kirsehir Ahi Evran Univ, Dept Mol Biol & Genet, Kirsehir, Turkey
[3] Kirsehir Ahi Evran Univ, Dept Elect Elect Engn, Kirsehir, Turkey
关键词
Molecular docking; anti-apoptotic proteins; ADMET; drug-likeness; toxicology; DISCOVERY;
D O I
10.1080/01480545.2021.1894711
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cancer is an uncontrolled growth of normal cells and apoptosis has an important role in cancer progression and cancer treatment. Antiapoptotic proteins are overexpressed in several tumors including breast, brain, lung cancer cells. The protein-ligand interaction has a critical role in drug designing. The present study aims to evaluate the interaction of synthesized N-cyclohexylmethacrylamide (NCMA) with proteins using in silico molecular docking and toxicity analyses. The NCMA monomer was synthesized and characterized by our team, previously. Kinetics stability, binding affinities and toxic potential of protein-NCMA complex were examined with the aid of molecular simulation. The toxicity results of this study indicate that NCMA is a sample with low toxic potential. According to the docking results, NCMA may be a drug active substance with chemical modifications and toxicity results support this situation. The drug-likeness and ADMET parameters were screened properties of NCMA.
引用
收藏
页码:1963 / 1970
页数:8
相关论文
共 36 条
  • [31] Crystal structure, DFT calculation, molecular docking, in vitro biological activity evaluation and in silico drug-likeness prediction of ( E)- N-(4-bromophenyl)-4-(2-(2-hydroxybenzylidene) hydrazine-1-carbonyl) benzenesulfonamide
    Liu, Tao
    Chen, Jianchao
    Fan, Chao
    Wu, Chengjun
    Sun, Tiemin
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1284
  • [32] 3D-QSAR, drug-likeness, ADMET prediction, and molecular docking studies in silico of novel 5-oxo-1-thioxo-4,5-dihydro-1H-thiazolo[3,4-a]quinazoline derivatives as MALT1 protease inhibitors for the treatment of B cell lymphoma
    Haloui, Rachid
    Daoui, Ossama
    Mkhayar, Khaoula
    El Yaqoubi, Mohamed
    Elkhattabi, Souad
    Haoudi, Amal
    Rodi, Youssef Kandri
    Ouazzani, Fouad Chahdi
    Chtita, Samir
    CHEMICAL PAPERS, 2023, 77 (04) : 2255 - 2274
  • [33] sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell
    Tian, Defeng
    Das, Sonia G.
    Doshi, Jignesh M.
    Peng, Jun
    Lin, Haling
    Xing, Chengguo
    CANCER LETTERS, 2008, 259 (02) : 198 - 208
  • [34] An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in human dopaminergic SH-SY5Y cells
    Akao, Y
    Maruyama, W
    Yi, H
    Shamoto-Nagai, M
    Youdim, MBH
    Naoi, M
    NEUROSCIENCE LETTERS, 2002, 326 (02) : 105 - 108
  • [35] One-pot synthesis, NMR, quantum chemical approach, molecular docking studies, drug-likeness and in-silico ADMET prediction of novel 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(furan-2-yl)-4,5-diphenyl-1H-imidazole derivatives
    Rajaraman, D.
    Anthony, L. Athishu
    Nethaji, P.
    Vallangi, Ravali
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1273
  • [36] KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells
    Mohan, Nishant
    Ai, Walden
    Chakrabarti, Mrinmay
    Banik, Naren L.
    Ray, Swapan K.
    MOLECULAR ONCOLOGY, 2013, 7 (03) : 464 - 474